Spirometry pattern recognition is one of the most consequential interpretive tasks in respiratory medicine. Getting it wrong means patients may be misdiagnosed, undertreated, or subjected to unnecessary investigations. Obstructive patterns are identified by a reduced FEV1/FVC ratio, while restrictive patterns are characterized by reduced lung volumes with a preserved or elevated ratio. The challenge is that these two patterns can overlap, mimic one another, and in some cases, restriction can exist even when spirometry appears normal. Software-assisted classification tools, when built on current ATS guidelines and validated normal values, help clinicians and respiratory scientists navigate this complexity with greater consistency and confidence.

TL;DR

• Obstructive and restrictive spirometry patterns have distinct but sometimes overlapping signatures that are easy to misinterpret without structured guidance.

• A normal FEV1/FVC ratio does not rule out restriction, a clinically significant finding supported by recent research.

• Misinterpretation of spirometry results carries real patient risk, including missed diagnoses and incorrect treatment pathways.

• Software that automates pattern classification based on current guidelines reduces human error and improves reporting consistency.

• Rezibase is a cloud-based respiratory reporting platform built by respiratory scientists to support accurate, guideline-aligned interpretation.

What Is the Difference Between Obstructive and Restrictive Spirometry Patterns?

Obstructive and restrictive patterns represent fundamentally different physiological problems, and distinguishing them is the foundation of respiratory diagnosis.

Obstructive pattern:

• Characterized by airflow limitation, where air cannot leave the lungs efficiently

• Key marker: reduced FEV1/FVC ratio (typically below the lower limit of normal)

• Common causes: asthma, COPD, bronchiectasis

• Flow-volume loop shows a concave (scooped) expiratory curve

Restrictive pattern:

• Characterized by reduced lung volumes, where the lungs cannot fully expand

• Key marker: reduced TLC (total lung capacity), with FEV1/FVC ratio preserved or elevated

• Common causes: pulmonary fibrosis, obesity, neuromuscular disease, pleural disease

• Flow-volume loop may appear small but normal in shape

According to the American Academy of Family Physicians (AAFP), the FEV1/FVC ratio is the primary tool for differentiating obstructive from restrictive conditions, and additional maneuvers such as the maximal voluntary ventilation (MVV) test can be used to help confirm findings.

Why Is Spirometry Misinterpretation So Common?

Spirometry interpretation is more nuanced than it appears, and several structural factors contribute to diagnostic error.

The core challenges:

• Normal values vary by population: Reference equations differ by age, sex, height, and ethnicity. Using the wrong reference set shifts what counts as "normal" and can produce false positives or negatives.

• Pattern overlap: Mixed obstructive-restrictive defects exist and do not fit neatly into either category without full lung volume testing.

• Contextual reliance: A spirometry result cannot be interpreted in isolation. Clinical history, symptoms, and other tests all influence the final interpretation.

• Inconsistent training: Not all clinicians interpreting spirometry results have formal respiratory physiology training.

As ndd Medical notes, the FEV1/FVC ratio helps differentiate whether restrictive or obstructive lung disease exists, but interpretation requires understanding what each value actually represents in context, not just whether a number falls above or below a threshold.

Can Restriction Exist When Spirometry Looks Normal?

Yes, and this is one of the most clinically important and underappreciated findings in respiratory medicine.

A 2025 retrospective cohort study published on medRxiv found that restriction with normal spirometry was associated with increased all-cause mortality, with an adjusted hazard ratio of 1.45 (95% CI 1.34 to 1.57). The researchers found this to be an interesting and notable finding, suggesting that spirometry alone may not capture the full picture of restrictive physiology in all patients.

This matters for clinical practice because:

• Patients with preserved FEV1/FVC ratios may still have clinically significant restriction

• Relying on spirometry alone without full lung volume testing may lead to missed diagnoses

• Software tools that flag borderline or ambiguous results can prompt further investigation rather than a false reassurance

The implication is clear: pattern recognition software should not simply classify results as "normal" or "abnormal" based on a single ratio. It should be designed to surface nuance.

How Does Software-Assisted Classification Improve Accuracy?

Software-assisted classification reduces the cognitive load on the reporting clinician and enforces consistency across a lab's entire output.

Key benefits of structured classification tools:

Critically, software does not replace clinical judgment. It structures the interpretive environment so that judgment is applied to the right questions, not spent on administrative or computational steps.

What Should Respiratory Labs Look for in a Reporting Platform?

Not all respiratory reporting software is built the same. Labs evaluating platforms should prioritize tools that are purpose-built for respiratory science, not adapted from general clinical documentation systems.

Essential capabilities:

• Guideline-aligned algorithms: The platform should classify patterns according to current ATS/ERS standards, not legacy criteria.

• Updatable normal values library: Reference equations must reflect current validated populations and be easy to update as standards evolve.

• Vendor-neutral data import: Labs use equipment from multiple manufacturers. The platform should accept data from any device without manual re-entry.

• Integrated flow-volume loop display: Visual review of the loop is part of quality assurance, not optional.

• Structured reporting templates: Reports should guide the interpreter through a consistent workflow, reducing the chance of omission.

This is where Rezibase stands out. Built by respiratory scientists Peter Rochford and the late Jeff Pretto, Rezibase was designed around the actual workflows of clinical physiology labs. Its Normal Values Library is pre-configured and regularly updated, its Magic Import function extracts discrete data including flow-volume loops directly from device reports, and its reporting module is aligned to ATS guidelines. Being vendor-neutral means labs are not locked into a single equipment manufacturer.

Frequently Asked Questions

What is the most reliable spirometry marker for identifying obstruction?
The FEV1/FVC ratio below the lower limit of normal (LLN) is the primary marker for obstruction. FEV1 alone can be misleading without the ratio context.

Can spirometry confirm restriction on its own?
Not definitively. Spirometry can suggest restriction through a reduced FVC with normal FEV1/FVC, but confirmation requires full lung volume measurement, typically via body plethysmography or gas dilution.

What is a mixed obstructive-restrictive pattern?
A mixed pattern occurs when both airflow limitation and reduced lung volumes are present simultaneously. It requires full lung function testing to identify and is often associated with complex or multi-system disease.

How often should normal value references be updated in reporting software?
Normal value references should be reviewed whenever new validated equations are published or when ATS/ERS guidelines are updated. Software platforms should make this update process straightforward and auditable.

What role does the flow-volume loop play in pattern recognition?
The shape of the flow-volume loop provides visual confirmation of the numerical result. An obstructive pattern shows a concave expiratory limb, while a restrictive pattern shows a proportionally small but normally shaped loop. Atypical shapes can indicate poor technique or upper airway obstruction.

Is software-assisted interpretation suitable for all clinical settings?
Software-assisted tools are appropriate for any setting where spirometry is performed and reported, including hospital labs, private clinics, and community respiratory services. The key is that the software must be configured correctly for the clinical context.

What happens when spirometry results are ambiguous or borderline?
Ambiguous results should trigger a structured review process, including consideration of full lung function testing, clinical correlation, and repeat testing if effort was suboptimal. Good reporting software flags these cases rather than forcing a binary classification.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, trusted by over 35 sites including NHS hospitals in the UK and NSW Health in Australia. Built by respiratory scientists and backed by Cardiobase, Rezibase is designed to reduce clinical risk, eliminate vendor lock-in, and make life easier for the scientists and clinicians who depend on accurate respiratory data every day.

Ready to see how Rezibase supports accurate, guideline-aligned spirometry reporting? Visit rezibase.com to learn more or start your 30-day free trial.

References

• American Academy of Family Physicians. An Approach to Interpreting Spirometry. https://www.aafp.org/pubs/afp/issues/2004/0301/p1107.html

• ndd Medical. What do these spirometry results really mean?. https://nddmed.com/blog/2023/spirometry-interpretation-a-simple-guide/

• medRxiv. Restriction with Normal Spirometry: A Retrospective Cohort Study. https://www.medrxiv.org/content/10.64898/2025.12.15.25342141v1.full-text